AGP Picks
View all

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
fallback image
5 hours ago

Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes

GlobeNewswire, Inc.

fallback image
Sep. 30, 2026

Influential Women Features Vita Oyler: Champions Resilience Through Chronic Pain Rehabilitation And Holistic Wellness

EIN Presswire

fallback image
Sep. 30, 2026

Italfarmaco Presents New Givinostat (Duvyzat®) Clinical Data Supporting Preservation of Upper Limb Function in Duchenne Muscular Dystrophy Patients at the 2026 World Muscle Society Congress

GlobeNewswire, Inc.

fallback image
Sep. 30, 2026

Santhera Pharmaceuticals Half Year Results for the six months ending 30 June 2026

GlobeNewswire, Inc.

fallback image
an hour ago

MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting

GlobeNewswire, Inc.

fallback image
Sep. 29, 2026

Global Software as a Medical Device Market to Observe Stupendous Growth at a CAGR of ~17% by 2034 | DelveInsight

GlobeNewswire, Inc.

fallback image
5 hours ago

Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes

GlobeNewswire, Inc.

fallback image
Sep. 29, 2026

NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease

GlobeNewswire, Inc.

fallback image
Sep. 29, 2026

VCD Medical Receives U.S. FDA 510(k) Clearance for VEnice™ Vein Closure Device

GlobeNewswire, Inc.

fallback image
Sep. 29, 2026

Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business

GlobeNewswire, Inc.

fallback image
Sep. 29, 2026

4BIO Capital leads €40 Million ($45M) seed financing of Aptadir Therapeutics to advance first-in-class demethylating medicines

GlobeNewswire, Inc.

fallback image
Sep. 29, 2026

APTADIR RAISES A €40M ($45M) SEED FINANCING TO ADVANCE FIRST-IN-CLASS DEMETHYLATING MEDICINES

GlobeNewswire, Inc.

fallback image
Sep. 28, 2026

Live Whole Health #336: Spaghetti squash is your fall must-try

U.S. Department of Veterans Affairs

fallback image
Sep. 28, 2026

Acne Vulgaris Market Set for Significant Growth During the Forecast Period (2026–2036), Amid Rising Disease Burden and Therapeutic Advances | DelveInsight

GlobeNewswire, Inc.

fallback image
Sep. 28, 2026

Alex Bodi and Prof. Dr Dieter Lazik sign a contract for ALPHA WHEY and BODI Energy Drink

GlobeNewswire, Inc.

fallback image
Sep. 26, 2026

Chinese Brands Going Global — Worldwide Tour (Europe Stop) holds events in Switzerland, Italy

GlobeNewswire, Inc.

fallback image
an hour ago

Galgotias University Soars 24 Places to Rank 41st in India in Times Higher Education World University Rankings 2027

EIN Presswire

fallback image
3 hours ago

Galgotias University Soars 24 Places to Rank 41st in India in Times Higher Education World University Rankings 2027

EIN Presswire

fallback image
2 hours ago

Galgotias University Soars 24 Places to Rank 41st in India in Times Higher Education World University Rankings 2027

EIN Presswire

fallback image
an hour ago

Galgotias University Soars 24 Places to Rank 41st in India in Times Higher Education World University Rankings 2027

EIN Presswire

Sign up for:

Health Watch Italy

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by: